Danielle Marie Aubuchon, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 19515 Brune Pkwy, Warrenton, MO 63383 Phone: 888-403-1071 Fax: 636-456-5014 |
Mr. Patrick Michael Shanahan, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1428 N State Highway 47, Warrenton, MO 63383 Phone: 636-359-6445 |
Carmen Kay Schulze, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2 Buckhorn Ct, Warrenton, MO 63383 Phone: 636-578-6864 |
Melissa Kay Schaumberg, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 19515 Brune Pkwy, Warrenton, MO 63383 Phone: 888-403-1071 |
Ms. Bonnie J Wessler, L.C.S.W. Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 404 E Booneslick Rd, Suite B, Warrenton, MO 63383 Phone: 636-456-7715 Fax: 636-456-0935 |
Lynn Renee Joyce, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 283 W Veterans Memorial Pkwy, Warrenton, MO 63383 Phone: 636-359-7322 Fax: 636-235-0236 |
Ms. Kathleen M Blondin, MSW LCSW ACSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 404 E Booneslick, Ste B, Warrenton, MO 63383 Phone: 636-456-7715 Fax: 636-456-0935 |
News Archive
Haber, Inc. ("Haber"), (OTC: HABE), a Delaware corporation headquartered in Arlington, Mass., with proprietary technologies in the separations sciences and environmentally friendly processing of gold bearing ores, announced today that it has formed a wholly owned subsidiary incorporated in Delaware called "EMP Diagnostics Inc." ("EDI"). The business of the new company will focus on the application of Haber's Electromolecular Propulsion technology (EMP). EMP is a separation technology that achieves unrivaled molecular separation speeds and has other unique capabilities not attainable with electrophoresis or liquid chromatography.
The class of antidepressant medications known as selective serotonin reuptake inhibitors may be associated with an increased rate of bone loss in older men and women, according to two articles in the June 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Many times, people with heart disease have few visible symptoms. This is one of the reasons why heart disease is the number one killer for both men and women in America. Saint Louis University and SLUCare offer a non-invasive test that could save your life or the life of someone you love.
A research team at the University of Alberta, Canada, led by Dr. Daniel Limonta, has described two novel molecules with broad antiviral properties that are effective against a range of virus types, including SARS-CoV-2.
Nymox Pharmaceutical Corporation today announced new 2010 positive results from a long term outcome study of NX-1207 for benign prostatic hyperplasia (BPH). The study evaluated symptomatic progress of U.S. patients involved in the Company's NX02-0012 and NX02-0013 Phase 1-2 studies of NX-1207 initially undertaken in 2003. Patients treated with NX-1207 were followed-up on an unselected and as available basis and assessed for symptomatic improvement, treatment outcomes, and durability of efficacy 6 ½ years after a single treatment with NX-1207.
› Verified 5 days ago